Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Micronized fenofibrate receives FDA approval

Feb. 16, 1998

Hypocholesterolemic agents disclosed by Warner-Lambert

Feb. 16, 1998

New antiobesity agent now being distributed in U.S.

Feb. 13, 1998

Pamidronate beneficial in multiple myeloma with bone complications

Feb. 13, 1998

Pharmacia & Upjohn reveals novel compounds and novel methods of treating NIDDM

Feb. 13, 1998

Sankyo researches new antidiabetic agents

Feb. 13, 1998

Goralatide: a candidate hematopoietic agent from Beaufour Ipsen

Feb. 12, 1998

Adenosine agonists with antilipolytic activity described by Glaxo

Feb. 12, 1998

Macritonin clinical trial update

Feb. 11, 1998

SGLT inhibitors under evaluation at Tanabe as antidiabetic agents

Feb. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...